Schonfeld Strategic Advisors’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-75,000
| Closed | -$757K | – | 2845 |
|
|
2022
Q4 | $757K | Buy |
75,000
+1,556
| +2% | +$15.7K | 0.01% | 1292 |
|
|
2022
Q3 | $729K | Buy |
73,444
+58,400
| +388% | +$580K | 0.01% | 1471 |
|
|
2022
Q2 | $149K | Sell |
15,044
-77,974
| -84% | -$772K | ﹤0.01% | 1944 |
|
|
2022
Q1 | $917K | Buy |
93,018
+600
| +0.6% | +$5.92K | 0.01% | 978 |
|
|
2021
Q4 | $909K | Buy |
92,418
+42,418
| +85% | +$417K | 0.01% | 921 |
|
|
2021
Q3 | $487K | Hold |
50,000
| – | – | 0.01% | 1209 |
|
|
2021
Q2 | $484K | Buy |
+50,000
| New | +$484K | 0.01% | 1179 |
|